EP Patent

EP2680899A4 — Medicament delivery device for administration of opioid antagonists including formulations for naloxone

Assigned to kaleo Inc · Expires 2017-07-26 · 9y expired

What this patent protects

Patent listed against naloxone-hydrochloride.

Drugs covered by this patent

naloxone-hydrochloride (Naloxone Hydrochloride) · Pfizer Inc.

Patent Metadata

Patent number: EP2680899A4
Jurisdiction: EP
Classification: —
Expires: 2017-07-26
Drug substance claim: No
Drug product claim: No
Assignee: kaleo Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.